Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

September 2016 - FRMC

Department

News Connection
09/15/2016
England’s National Health Service (NHS) is intentionally hindering access to the pricey hepatitis C drugs Sovaldi (sofosbuvir; Gilead) and Harvoni (ledipasvir/sofosbuvir; Gilead) due to worries over how it will afford them, according to an...
England’s National Health Service (NHS) is intentionally hindering access to the pricey hepatitis C drugs Sovaldi (sofosbuvir; Gilead) and Harvoni (ledipasvir/sofosbuvir; Gilead) due to worries over how it will afford them, according to an...
England’s National Health...
09/15/2016
First Report Managed Care

Advertisement

Advertisement

Advertisement